- £148.43m
- £751.33m
- £741.10m
- 17
- 80
- 44
- 42
2020 January 31st | 2021 January 31st | 2022 January 31st | R2023 January 31st | 2024 January 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | Interim Report | ARS |
Standards: | IFRS | IFRS | IFRS | — | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 797 | 338 | 377 | 664 | 741 |
Cost of Revenue | |||||
Gross Profit | 371 | 237 | 234 | 415 | 440 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Operating Interest Expense / Income | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,098 | 399 | 401 | 936 | 870 |
Operating Profit | -301 | -61.2 | -23.5 | -273 | -129 |
Net Income Before Taxes | -301 | -61.2 | -23.5 | -273 | -129 |
Provision for Income Taxes | |||||
Net Income After Taxes | -313 | -67.8 | -28 | -273 | -113 |
Net Income Before Extraordinary Items | |||||
Net Income | -313 | -67.8 | -28 | -273 | -113 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -313 | -67.8 | -28 | -273 | -113 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.575 | -0.31 | -0.175 | -0.677 | 0.08 |
Dividends per Share |